Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24)now available for Polish patients: creation and validationof the Polish language version
Krajewski, Piotr ; Bardowska, Klaudia ; Matusiak, Lukasz ; Szepietowska, Marta ; Tyczynska, Kinga ; Marron, Servando ; Aragones, Lucía ; Szepietowski, Jacek
Resumen: Introduction: Hidradenitis suppurativa (HS) is a chronic, inflammatory skin disorder with a well-documented impact on quality of life (QoL). Due to the very distinctive features of HS the clinical picture, and lack of specific questions, generic dermatology QoL questionnaires cannot adequately reflect patients’ suffering.
Aim: To translate and validate the Polish version of the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire.
Material and methods: The standardized translation process included forward and backward translation from the English version of the instrument. The final version was subsequently validated on a group of 30 HS patients, who
completed the questionnaire twice. Internal consistency, test-retest reliability, and reproducibility of the results were also analysed.
Results: The Polish version of HSQoL-24 showed excellent internal consistency, with a Cronbach α coefficient of 0.908. Moreover, excellent reproducibility of the results was observed, with an intraclass correlation coefficient of 0.908. The HSQoL global score correlated positively with Dermatology Life Quality Index (DLQI) and Hidradenitis Suppurativa Quality of Life (HiSQoL) questionnaire.
Conclusions: The Polish version of HSQoL-24 has excellent internal consistency, good reproducibility, and adequate validity. It may be of help in assessing QoL impairment in HS patients in daily practice and research.
Idioma: Inglés
DOI: 10.5114/ada.2022.114885
Año: 2022
Publicado en: Postepy Dermatologii i Alergologii 39, 6 (2022), 1053-1058
ISSN: 1642-395X
Factor impacto JCR: 1.4 (2022)
Categ. JCR: DERMATOLOGY rank: 59 / 70 = 0.843 (2022) - Q4 - T3
Categ. JCR: ALLERGY rank: 25 / 28 = 0.893 (2022) - Q4 - T3
Factor impacto CITESCORE: 2.3 - Medicine (Q3)
Factor impacto SCIMAGO: 0.384 - Immunology and Allergy (Q3) - Dermatology (Q3)
Tipo y forma: Artículo (Versión definitiva)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original.
Exportado de SIDERAL (2024-03-18-17:05:02)
Visitas y descargas
Aim: To translate and validate the Polish version of the Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) questionnaire.
Material and methods: The standardized translation process included forward and backward translation from the English version of the instrument. The final version was subsequently validated on a group of 30 HS patients, who
completed the questionnaire twice. Internal consistency, test-retest reliability, and reproducibility of the results were also analysed.
Results: The Polish version of HSQoL-24 showed excellent internal consistency, with a Cronbach α coefficient of 0.908. Moreover, excellent reproducibility of the results was observed, with an intraclass correlation coefficient of 0.908. The HSQoL global score correlated positively with Dermatology Life Quality Index (DLQI) and Hidradenitis Suppurativa Quality of Life (HiSQoL) questionnaire.
Conclusions: The Polish version of HSQoL-24 has excellent internal consistency, good reproducibility, and adequate validity. It may be of help in assessing QoL impairment in HS patients in daily practice and research.
Idioma: Inglés
DOI: 10.5114/ada.2022.114885
Año: 2022
Publicado en: Postepy Dermatologii i Alergologii 39, 6 (2022), 1053-1058
ISSN: 1642-395X
Factor impacto JCR: 1.4 (2022)
Categ. JCR: DERMATOLOGY rank: 59 / 70 = 0.843 (2022) - Q4 - T3
Categ. JCR: ALLERGY rank: 25 / 28 = 0.893 (2022) - Q4 - T3
Factor impacto CITESCORE: 2.3 - Medicine (Q3)
Factor impacto SCIMAGO: 0.384 - Immunology and Allergy (Q3) - Dermatology (Q3)
Tipo y forma: Artículo (Versión definitiva)
Debe reconocer adecuadamente la autoría, proporcionar un enlace a la licencia e indicar si se han realizado cambios. Puede hacerlo de cualquier manera razonable, pero no de una manera que sugiera que tiene el apoyo del licenciador o lo recibe por el uso que hace. No puede utilizar el material para una finalidad comercial. Si remezcla, transforma o crea a partir del material, deberá difundir sus contribuciones bajo la misma licencia que el original. Exportado de SIDERAL (2024-03-18-17:05:02)
Enlace permanente:
Visitas y descargas
Este artículo se encuentra en las siguientes colecciones:
Artículos
Registro creado el 2023-02-24, última modificación el 2024-03-19